Bone & Cartilage

With a vast team of more than 100 experts, the CHU and ULg have created an internal network of collaborations between fundamental research and clinical studies. This mix provides us unique insights and capabilities that allow us to develop new technologies and therapies for the well-being of the patient. We can help you in driving your research projects from early discovery, through preclinical up to the clinical phase by offering:
  • Mechanistic and in silico modeling
  • Functional cellular assays
  • Animal models, biomarkers and analysis methods for pain, lameness, mechanical properties of tissues and biomaterials
  • Clinical study and radiological monitoring expertise
  • Strong clinical expertise in osteoporosis, osteoarthritis and sarcopenia
  • Validated and qualified biomarkers (8 patented in OA) for diagnosis and monitoring
 

Cardiology

Cardiology has always been a mainstay in Liège. Cardiovascular research and care in Liège is organized in different, specialized departments and multi-disciplinary teams encompassing scientists, specialists in cardiology, experts in imaging, cardiovascular surgeons, and engineers interact on daily basis. Through this maze of internal networks between the ULg and the CHU, we aim to become a reference center for personalized treatment. We are excited to expand our external collaborations even more with academic and industrial partners. As such, we can support your cardiology projects throughout its development pathway by providing:
  • Extensive insight in the genetic and molecular processes behind thrombosis
  • Mathematical models of the cardiovascular system
  • Expertise in ex vivo functional tests
  • Various dedicated animal models to study cardiovascular diseases
  • Clinical experience in monitoring and management of various cardio-pathologies
  • Specialized imaging techniques
 

Neurology

The medical community in Liège has a longstanding tradition in neurology, resulting in solutions to improve the life of patients with Alzheimer’s disease, epilepsy, glioblastoma, Parkinson’s disease, sleeping disorders and Multiple Sclerosis. A strong link between clinical research and basic/translational research is the hallmark of Neurosciences at ULg/CHU. Neurosciences have 3 major components: the Department of Clinical Neurosciences, the GIGA Neurosciences and the CRC-In vivo imaging. Several research areas have received particular attention and the teams have acquired significant expertise in identification of new cellular and molecular mechanisms involved in key developmental processes, and more specifically in neuroendocrine and neurochemical mechanisms - amongst many others. The teams are excited to collaborate and/or support your research projects from early discovery up to the clinical phase providing:
  • In silico models
  • Cell lines for in vitro experiments
  • Electrophysiology
  • Mouse models
  • Patient treatment and follow-up
  • Pre-clinical and clinical imaging capabilities
  • Human biological samples for testing
 

Oncology

Cancer research at University of Liège is focused on the molecular and cellular mechanisms involved in cancer genesis, cancer progression and metastatic dissemination. To achieve their goals, the researchers have developed close collaborations with clinicians of the University Hospital (CHU de Liège). Their experimental and translational approaches allow an in-depth investigation of intrinsic features of primary tumor cells, metastatic tumor cells and circulating tumor cells. Special emphasis is given on the identification of predictive, prognostic and diagnostic markers of cancers with putative interest to develop personalized treatments or overcome tumor resistance or adaptation to therapies currently used in clinic. With this aim advanced epigenetic, genomic, proteomic and metabolomic technologies are applied to human samples or sophisticated in vitro and in vivo models. Research programs cover a wide range of areas, such as:
  • Complex interactions between cancer cells and their molecular and cellular environments with a special focus on extracellular matrix, immune cells, inflammatory cells and endothelial cells of blood or lymphatic vessels
  • Abnormal tissue remodelling, impaired vessel functions and excessive inflammation
  • Mesenchymal Stem Cells for tissue repair and immunosuppression (notably in the field of HSC transplantation) and the ability of regulatory T cells (Tregs) to attenuate experimental graft-versus-host disease (GVHD)